scholarly article | Q13442814 |
P356 | DOI | 10.1161/CIRCULATIONAHA.105.539221 |
P698 | PubMed publication ID | 16103235 |
P2093 | author name string | Christian Schulz | |
Michael Lorenz | |||
Ildiko Konrad | |||
Jon Frampton | |||
Steffen Massberg | |||
Elisabeth Kremmer | |||
Elisabeth Kennerknecht | |||
Nikolaus Plesnila | |||
Meinrad Gawaz | |||
Martina Rudelius | |||
Siegmund Braun | |||
Katrin Schürzinger | |||
Nikla R Emambokus | |||
Susanne Sauer | |||
P433 | issue | 8 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | cerebral infarction | Q1209150 |
P304 | page(s) | 1180-1188 | |
P577 | publication date | 2005-08-15 | |
P1433 | published in | Circulation | Q578091 |
P1476 | title | Platelet adhesion via glycoprotein IIb integrin is critical for atheroprogression and focal cerebral ischemia: an in vivo study in mice lacking glycoprotein IIb. | |
P478 | volume | 112 |
Q38804583 | Adhesion Molecules: Master Controllers of the Circulatory System. |
Q37279053 | Atherosclerosis proceeds independently of thrombin-induced platelet activation in ApoE-/- mice |
Q40783418 | CalDAG-GEFI Deficiency Reduces Atherosclerotic Lesion Development in Mice. |
Q53471537 | Clopidogrel significantly lowers the development of atherosclerosis in ApoE-deficient mice in vivo. |
Q30494712 | Disruption of SEMA4D ameliorates platelet hypersensitivity in dyslipidemia and confers protection against the development of atherosclerosis |
Q39592493 | EMMPRIN (CD147/basigin) mediates platelet-monocyte interactions in vivo and augments monocyte recruitment to the vascular wall |
Q47551614 | Endothelial Cell-Derived Von Willebrand Factor, But Not Platelet-Derived, Promotes Atherosclerosis in Apolipoprotein E-Deficient Mice |
Q93085548 | Eosinophil-platelet interactions promote atherosclerosis and stabilize thrombosis with eosinophil extracellular traps |
Q34391705 | Fractalkine is expressed in early and advanced atherosclerotic lesions and supports monocyte recruitment via CX3CR1. |
Q27318499 | Functional comparison of induced pluripotent stem cell- and blood-derived GPIIbIIIa deficient platelets |
Q38502107 | Gap junctions and connexin hemichannels in the regulation of haemostasis and thrombosis. |
Q30650321 | Genetic deletion of platelet glycoprotein Ib alpha but not its extracellular domain protects from atherosclerosis |
Q30450312 | High platelet reactivity on clopidogrel therapy correlates with increased coronary atherosclerosis and calcification: a volumetric intravascular ultrasound study |
Q35588157 | How platelets safeguard vascular integrity |
Q41309425 | Hypoxia impairs agonist-induced integrin αIIbβ3 activation and platelet aggregation |
Q50554991 | Impact of glycoprotein VI and platelet adhesion on atherosclerosis--a possible role of fibronectin. |
Q27342617 | Impaired integrin β3 delays endothelial cell regeneration and contributes to arteriovenous graft failure in mice |
Q47913269 | Induced Pluripotent Stem Cell-Derived Megakaryocytes and Platelets for Disease Modeling and Future Clinical Applications |
Q30481913 | Inflammation induces hemorrhage in thrombocytopenia |
Q37386451 | Intercellular communication in atherosclerosis. |
Q26822941 | Leukocyte integrins: role in leukocyte recruitment and as therapeutic targets in inflammatory disease |
Q33819619 | Leukocyte-endothelial interactions in inflammation |
Q104134981 | Mild hyperlipidemia in mice aggravates platelet responsiveness in thrombus formation and exploration of platelet proteome and lipidome |
Q38125279 | Molecular biology of atherosclerosis |
Q60479077 | Oxidative stress in cardiovascular disease |
Q38151563 | Pharmacology of the new P2Y12 receptor inhibitors: insights on pharmacokinetic and pharmacodynamic properties. |
Q37903934 | Platelet adhesion and activation mechanisms in arterial thrombosis and ischaemic stroke |
Q30837682 | Platelet adhesion receptors do not modulate infarct volume after a photochemically induced stroke in mice |
Q37058252 | Platelet-lymphocyte cross-talk |
Q90403621 | Platelets Are at the Nexus of Vascular Diseases |
Q34019069 | Platelets and their chemokines in atherosclerosis-clinical applications |
Q33387350 | Platelets contribute to postnatal occlusion of the ductus arteriosus |
Q36328825 | Platelets in inflammation and atherogenesis. |
Q26852677 | Platelets in inflammation: regulation of leukocyte activities and vascular repair |
Q37035357 | Platelets modulate atherogenesis and progression of atherosclerotic plaques via interaction with progenitor and dendritic cells. |
Q36238074 | Platelets secrete stromal cell-derived factor 1alpha and recruit bone marrow-derived progenitor cells to arterial thrombi in vivo |
Q38016490 | Role of platelets as mediators that link inflammation and thrombosis in atherosclerosis |
Q63407959 | Signalling through Src family kinase isoforms is not redundant in models of thrombo-inflammatory vascular disease |
Q37071125 | Species differences in small molecule binding to alpha IIb beta 3 are the result of sequence differences in 2 loops of the alpha IIb beta propeller |
Q30488839 | Structural and therapeutic insights from the species specificity and in vivo antithrombotic activity of a novel alphaIIb-specific alphaIIbbeta3 antagonist. |
Q34917692 | The GPVI-Fc fusion protein Revacept improves cerebral infarct volume and functional outcome in stroke |
Q36445381 | The PPAR-Platelet Connection: Modulators of Inflammation and Potential Cardiovascular Effects |
Q46530171 | The immunoadhesin glycoprotein VI-Fc regulates arterial remodelling after mechanical injury in ApoE-/- mice |
Q34145922 | eNOS protects from atherosclerosis despite relevant superoxide production by the enzyme in apoE mice. |
Search more.